Research graph
References from The association between HIV pretreatment drug resistance and virological outcomes in children and adults in sub-Saharan Africa: A systematic review and meta-analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Unresolved reference
External reference
Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling study
10.1097/01.aids.0000433239.01611.52 · 2014 · External reference
Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation
10.1097/qad.0000000000000082 · 2014 · External reference
Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya
10.1097/qai.0000000000000312 · 2014 · External reference
Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial
10.1016/s2352-3018(19)30337-6 · 2020 · External reference
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study
10.1016/s1473-3099(11)70255-9 · 2012 · External reference
Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal Kenya
10.1371/journal.pone.0210559 · 2019 · External reference
Does Tenofovir-containing First-line Antiretroviral Therapy Mitigate the Impact of Pretreatment Non-nucleoside Reverse Transcriptase Inhibitor Drug Resistance?
10.1093/cid/ciy1070 · 2019 · External reference
The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa
10.1097/qad.0000000000002588 · 2020 · External reference
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial
10.1093/cid/civ102 · 2015 · External reference
Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children
10.1093/jac/dkx188 · 2017 · External reference
Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda
10.1089/aid.2014.0043 · 2014 · External reference
Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan women
10.1097/qad.0000000000002134 · 2019 · External reference
HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatment
10.1097/qad.0000000000003182 · 2022 · External reference
The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study
10.1186/s12879-020-4933-z · 2020 · External reference
Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa. Clinical infectious diseases: an official publication of the
10.1093/cid/civ656 · 2015 · External reference
Pretreatment HIV drug resistance predicts accumulation of new mutations in ART-naïve Ugandan children
10.1111/apa.15320 · 2020 · External reference
Pretreatment HIV drug resistance among adults initiating ART in Namibia
10.1093/jac/dky278 · 2018 · External reference
Rates and Correlates of Short Term Virologic Response among Treatment-Naïve HIV-Infected Children Initiating Antiretroviral Therapy in Ethiopia: A Multi-Center Prospective Cohort Study
10.3390/pathogens8040161 · 2019 · External reference
Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005–2013
10.1089/apc.2018.0020 · 2018 · External reference
Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi
10.1186/s12981-020-00282-3 · 2020 · External reference
High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali
10.1097/inf.0000000000001575 · 2017 · External reference
Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals
10.1093/jac/dkaa343 · 2020 · External reference
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
10.1038/s41467-020-19801-x · 2020 · External reference
HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine
10.1097/qad.0b013e3283492180 · 2011 · External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
2021 · External reference
Unresolved reference
1878 · External reference
High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children
10.7448/ias.19.1.21140 · 2016 · External reference
Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia
10.1097/qai.0000000000000509 · 2015 · External reference
Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children
10.1093/cid/ciq161 · 2011 · External reference
Pre-treatment drug resistance among patients initiating antiretroviral therapy (ART) in Zimbabwe: 2008–2010
10.1186/s13104-016-2101-8 · 2016 · External reference
Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?
10.1186/s12985-016-0628-x · 2016 · External reference
Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda
10.1089/aid.2011.0352 · 2012 · External reference
Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing
10.1038/s41598-018-25888-6 · 2018 · External reference
Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda
10.1089/aid.2009.0164 · 2010 · External reference
High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study
10.1097/qai.0000000000003027 · 2022 · External reference
Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries.
10.1093/cid/ciaa1161 · 2021 · External reference
Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis
10.1097/qad.0000000000000261 · 2014 · External reference
Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana
10.1097/qad.0000000000003041 · 2021 · External reference
A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa
10.1093/aje/kwr444 · 2012 · External reference
Assessment of selection bias due to dropouts in the follow-up of the Scania Public Health Cohort
10.1177/1403494820919544 · 2021 · External reference
Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis
2020 · External reference
High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan Africa
10.1097/qad.0000000000002580 · 2020 · External reference
Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis
10.1093/jac/dkw463 · 2017 · External reference
